AstraZeneca earnings up 55% driven by sales of cancer drugs
|
November 5, 2020 12:27 AM
LONDON (AP) — AstraZeneca said third-quarter earnings rose 55%, driven by increased sales of cancer treatments despite disruption caused by the COVID-19 pandemic.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
